ProZinc ™ (protamine zinc recombinant human insulin)

Committed to product availability

Boehringer Ingelheim Vetmedica, Inc., the manufacturer of PROZINC, is committed to helping you manage your cat's diabetes through a reliable supply of product. The human recombinant technology of PROZINC is not subject to raw material sourcing constraints, such as those that recently affected the availability of PZI VET^® (IDEXX Pharmaceuticals Inc.)

This means you can be confident in getting the medication your cat needs. You and your veterinarian can depend on the availability of PROZINC.

As a class, the use of any insulin when regulating a diabetic cat may be associated with side effects. The most common side effect reported in field studies was hypoglycemia. This is usually mild (lethargy, weak, trembling, uncoordinated, groggy, dazed), but may be serious and life-threatening (seizures, coma). If side effects occur, cat owners should contact their veterinarian immediately. Cats should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with PROZINC. Routine monitoring (blood parameters such as glucose and fructosamine and clinical signs) is essential to maintain a regulated cat. PROZINC insulin is contraindicated during episodes of hypoglycemia. Please refer to the package insert for complete product information.